Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
Arthritis Care & Research|March 17, 2012
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics RegisterMoetaza M Soliman, Kimme L Hyrich, Mark Lunt, et al.
Rheumatology (Oxford, England)|February 26, 2020
Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritisJames M Gwinnutt, Sarah Leggett, Mark Lunt, et al.
Rheumatology (Oxford, England)|September 6, 2023
Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RALianne Kearsley-Fleet, Aasiyah Rokad, Man-Fung Tsoi, et al.
Rheumatology (Oxford, England)|March 21, 2023
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RALianne Kearsley-Fleet, Aasiyah Rokad, Man-Fung Tsoi, et al.
Rheumatology (Oxford, England)|July 23, 2013
Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics RegisterFlora McErlane, Helen E Foster, Rebecca Davies, et al.
Clinical Rheumatology|December 4, 2016
Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritisMari Kihara, Rebecca Davies, Lianne Kearsley-Fleet, et al.
Rheumatology (Oxford, England)|December 25, 2009
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics RegisterPaul A C Lord, Tracey M Farragher, Mark Lunt, et al.
Rheumatology (Oxford, England)|November 14, 2019
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLaura Chadwick, Lianne Kearsley-Fleet, Nina Brown, et al.
Health and Quality of Life Outcomes|February 13, 2010
Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritisMark J Harrison, Mark Lunt, Suzanne M M Verstappen, et al.
Vaccine|November 17, 2007
Factors influencing the antibody response of dogs vaccinated against rabiesLorna J Kennedy, Mark Lunt, Annette Barnes, et al.
Pageof 21